Emergent BioSolutions (EBS) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Emergent BioSolutions (NYSE:EBS) Shareholder Returns Have Been Solid, Earning 285% in 1 Year
Simply Wall StDec 31, 2024 06:41 ET
Why Emergent BioSolutions Stock Blasted Higher Today
Yahoo FinanceDec 30, 2024 17:26 ET
Sector Update: Health Care Stocks Lower Monday Afternoon
MT NewswiresDec 30, 2024 13:48 ET
Crude Oil Gains 1%; Chicago PMI Falls In December
BenzingaDec 30, 2024 12:55 ET
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
BenzingaDec 30, 2024 10:23 ET
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
BenzingaDec 30, 2024 07:54 ET

Comments

Jaguar8

Dec 16, 2024 22:18

🟢Watchlist TUESDAY 12/17… quite busy. Squeezing in. NFA

$Tenaya Therapeutics (TNYA.US)$ Trial data on hypertrophic cardiomyopathy (HCM) at 8AM ET. Large float. SI 25.47%. COH $129.9M good for 16.2 months
$Biomea Fusion (BMEA.US)$ Covalent III Trial regarding Type 2 Diabetes mellitus out tomorrow 8AM ET. SI 44.16%. COH $62.4M good for 6.2 months
$Sidus Space (SIDU.US)$ Satellite launch Friday. May continue until launch. Low float. 0 shares LTB.COH $4.8M good for 4.2 months✅
$Maison Solutions (MSS.US)$ PR AH 12/...

39

3

11

Jaguar8

Dec 16, 2024 07:12

NEWS

$Emergent BioSolutions (EBS.US)$
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Emergent BioSolutions (NYSE: EBS) has received a $50 million contract option from BARDA for its CYFENDUS® anthrax vaccine. The deliveries are scheduled between now and April 2025. This follows a previous $30 million contract modification for the same vaccine. CYFENDUS®, FDA-approved in July 2023, is a two-dose anthrax vacci...

Trytosaveabit

Dec 16, 2024 07:02

News

$Emergent BioSolutions (EBS.US)$ Reuters
Just
Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted
Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025

EZ_money

Dec 10, 2024 13:16

$Emergent BioSolutions (EBS.US)$ 👈 this small float is the maker of narcan the drug that saves lives from opioid overdoses. Huge in the United States because of the cartels pushing fentanyl all over killing everyone.Hit them with narcan it's already saved countless lives. States are starting to require they have some on hand in schools. narcan will be sold all over in every pharmacy, sold to schools , jails, hospitals etc....only one thing like it but doesn't work on fentanyl like narcan does. N...

Emergent BioSolutions Inc.'s (NYSE:EBS) Institutional Investors Lost 11% Last Week but Have Benefitted From Longer-term Gains

1

EZ_money

Dec 10, 2024 05:22

$Emergent BioSolutions (EBS.US)$ buying back in ... BlackRock, vanguard purposely push assets down. this company has far too many good things happening with new CEO turning things around starting past year. it's bottomed out earlier this year guess who are the ones pushing it down.... they are the ones wanting to buy in cheaper
$Synopsys (SNPS.US)$ $Futu Holdings Ltd (FUTU.US)$ $IonQ Inc (IONQ.US)$

Investors Don't See Light At End Of Emergent BioSolutions Inc.'s (NYSE:EBS) Tunnel And Push Stock Down 26%

8

EBS Emergent BioSolutions

Trade Overview

Capital Trend

News

Comments